Twist Bioscience Corp (TWST)

Currency in USD
111.11
+6.07(+5.78%)
Real-time Data·
TWST is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
102.82111.21
52 wk Range
24.41219.71
Key Statistics
Prev. Close
105.04
Open
106.74
Day's Range
102.82-111.21
52 wk Range
24.41-219.71
Volume
937.31K
Average Volume (3m)
2.45M
1-Year Change
318.1406%
Book Value / Share
14.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TWST Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
128.92
Upside
+16.03%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price movements are quite volatile

Twist Bioscience Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Analyst Ratings

9 Buy
3 Hold
1 Sell
Ratings:
13 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 128.92
(+16.03% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
TD Cowen
Buy137.00+23.26%190.00MaintainNov 13, 2026
Baird
Buy135.00+21.46%187.00MaintainNov 13, 2026
Guggenheim
Buy150.00+34.95%212.00MaintainNov 13, 2026
Canaccord
Buy150.00+34.95%205.00MaintainNov 13, 2026
Jefferies
Hold125.00+12.46%150.00MaintainNov 12, 2026

Twist Bioscience Corp SWOT Analysis


DNA Revolution
Twist Bioscience leads synthetic biology with innovative DNA synthesis and storage solutions, positioning itself at the forefront of genomics and biotechnology advancements.
Financial Resilience
Despite projected near-term losses, Twist demonstrates strong revenue growth and improving gross margins, with a target of 50% by Q4 2025.
Storage Breakthrough
Discover how Twist's Century Archive Solution for DNA data storage could revolutionize the multi-billion dollar data storage market.
Market Outlook
Analysts project varied price targets ranging from $45 to $55, reflecting Twist's potential in expanding synthetic biology applications across industries.
Read full SWOT analysis

Twist Bioscience Corp Earnings Call Summary for Q4/2026

  • Twist Bioscience posted Q4 revenue of $126.6M, up 28% YoY, beating estimates by $3M; adjusted loss of $0.32/share topped forecasts by $0.06.
  • Company achieved positive adjusted EBITDA of $2.2M in Q4, a key milestone; gross margin improved to 53.1% from 51.3% year-ago on scale gains.
  • AI drug discovery revenue surged 175% in fiscal 2026 to $59.1M; company expects ~$100M in fiscal 2027 with triple-digit order growth continuing.
  • Fiscal 2027 guidance of $550M-$560M revenue (21% growth) and $75M capex disappointed investors; shares plunged 15% despite earnings beat.
  • CEO Leproust said profitability milestone provides 'more options' to invest in capacity and capabilities; company targets $1B+ revenue within existing facilities.
Last Updated: 11/12/2026, 10:28 PM
Read Full Transcript

Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
-0.32 / -0.38
Revenue / Forecast
126.6M / 123.59M
EPS Revisions
Last 90 days

TWST Income Statement

Compare TWST to Peers and Sector

Metrics to compare
TWST
Peers
Sector
Relationship
P/E Ratio
−52.0x−24.5x−0.2x
PEG Ratio
0.84−0.060.00
Price/Book
7.6x2.3x2.6x
Price / LTM Sales
14.7x15.1x2.7x
Upside (Analyst Target)
19.8%32.4%66.0%
Fair Value Upside
Unlock−25.7%10.8%Unlock

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. It offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; and Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, and other applications. It provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Employees
979

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
44.50M70.97%4.67B
Other Institutional Investors
30.73M29.03%3.23B
Public Companies & Retail Investors
0.000.00%0.00
Total
75.23M100.00%7.9B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FMR LLC15.44%9,680,2661,016,815
BlackRock, Inc.9.30%5,833,891612,792

People Also Watch

49.71
CRWV
-0.34%
283.67
NTRA
-1.67%
102.65
CBRS
+1.64%
63.73
TEM
-1.60%

FAQ

What Is the Twist Bioscience (TWST) Stock Price Today?

The Twist Bioscience stock price today is 111.11 USD.

What Stock Exchange Does Twist Bioscience Trade On?

Twist Bioscience is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Twist Bioscience?

The stock symbol for Twist Bioscience is "TWST."

What Is the Twist Bioscience Market Cap?

As of today, Twist Bioscience market cap is 6.94B USD.

What Is Twist Bioscience's Earnings Per Share (TTM)?

The Twist Bioscience EPS (TTM) is -2.08.

When Is the Next Twist Bioscience Earnings Date?

Twist Bioscience will release its next earnings report on Jan 29, 2027.

From a Technical Analysis Perspective, Is TWST a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Twist Bioscience Stock Split?

Twist Bioscience has split 0 times.

How Many Employees Does Twist Bioscience Have?

Twist Bioscience has 979 employees.

What is the current trading status of Twist Bioscience (TWST)?

As of Nov 17, 2026, Twist Bioscience (TWST) is trading at a price of 111.11 USD, with a previous close of 105.04 USD. The stock has fluctuated within a day range of 102.82 USD to 111.21 USD, while its 52-week range spans from 24.41 USD to 219.71 USD.

What Is Twist Bioscience (TWST) Price Target According to Analysts?

The average 12-month price target for Twist Bioscience is 128.92 USD, with a high estimate of 175 USD and a low estimate of 45 USD. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +16.03% Upside potential.

What Is the TWST Premarket Price?

TWST's last pre-market stock price is 107.32 USD. The pre-market share volume is 3,290.00, and the stock has decreased by 2.28, or 2.17%.

What Is the TWST After Hours Price?

TWST's last after hours stock price is 104.90 USD, the stock has decreased by -0.14, or -0.13%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.